Steward Partners Investment Advisory’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Steward Partners Investment Advisory’s Portfolio KNSA Stock Details KNSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$145K	Hold	2,266	–	–	﹤0.01%	2405
2026 Q1	$109K	Hold	2,266	–	–	﹤0.01%	2327
2025 Q4	$93.5K	Hold	2,266	–	–	﹤0.01%	2336
2025 Q3	$88K	Hold	2,266	–	–	﹤0.01%	2303
2025 Q2	$62.7K	Buy	2,266 +16	+0.7%	+$407	﹤0.01%	2360
2025 Q1	$50K	Hold	2,250	–	–	﹤0.01%	2386
2024 Q4	$44.5K	Hold	2,250	–	–	﹤0.01%	2400
2024 Q3	$56.2K	Hold	2,250	–	–	﹤0.01%	2173
2024 Q2	$42K	Hold	2,250	–	–	﹤0.01%	2187
2024 Q1	$44.4K	Hold	2,250	–	–	﹤0.01%	2176
2023 Q4	$39.5K	Hold	2,250	–	–	﹤0.01%	2096
2023 Q3	$39.1K	Buy	2,250 +250	+13%	+$4.21K	﹤0.01%	2022
2023 Q2	$28.2K	Hold	2,000	–	–	﹤0.01%	2116
2023 Q1	$21.5K	Hold	2,000	–	–	﹤0.01%	2222
2022 Q4	$30K	Hold	2,000	–	–	﹤0.01%	2046
2022 Q3	$26K	Hold	2,000	–	–	﹤0.01%	2092
2022 Q2	$19K	Hold	2,000	–	–	﹤0.01%	2246
2022 Q1	$20K	Hold	2,000	–	–	﹤0.01%	2363
2021 Q4	$24K	Hold	2,000	–	–	﹤0.01%	2246
2021 Q3	$23K	Hold	2,000	–	–	﹤0.01%	2263
2021 Q2	$28K	Hold	2,000	–	–	﹤0.01%	4384
2021 Q1	$37K	Buy	2,000 +1,000	+100%	+$20.5K	﹤0.01%	2146
2020 Q4	$18K	Buy	1,000 +500	+100%	+$8.78K	﹤0.01%	2097
2020 Q3	$8K	Buy	+500	New	+$9.39K	﹤0.01%	2219

Other funds holding KNSA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SSC

Spruce Street Capital New York $510M AUM

Steward Partners Investment Advisory's KNSA Position: Q2 2026 in Review

Steward Partners Investment Advisory held its Kiniksa Pharmaceuticals (KNSA) position steady in Q2 2026 at 2,266 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #2405.

Steward Partners Investment Advisory first reported a position in KNSA in Q3 2020 and has held it in 24 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

Steward Partners Investment Advisory held 2,266 shares of Kiniksa Pharmaceuticals worth $145K as of Q2 2026.
Steward Partners Investment Advisory left its Kiniksa Pharmaceuticals share count unchanged in Q2 2026.
Kiniksa Pharmaceuticals made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2405 holding.
Steward Partners Investment Advisory first reported a position in Kiniksa Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.